PRICES include / exclude VAT
Homepage>BS Standards>35 INFORMATION TECHNOLOGY. OFFICE MACHINES>35.240 Applications of information technology>35.240.80 IT applications in health care technology>BS EN ISO 11616:2017 Health informatics. Identification of medicinal products. Data elements and structures for unique identification and exchange of regulated pharmaceutical product information
Sponsored link
immediate downloadReleased: 2018-01-17
BS EN ISO 11616:2017 Health informatics. Identification of medicinal products. Data elements and structures for unique identification and exchange of regulated pharmaceutical product information

BS EN ISO 11616:2017

Health informatics. Identification of medicinal products. Data elements and structures for unique identification and exchange of regulated pharmaceutical product information

Format
Availability
Price and currency
English Secure PDF
Immediate download
312.18 EUR
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
31.22 EUR
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
93.65 EUR
English Hardcopy
In stock
312.18 EUR
Standard number:BS EN ISO 11616:2017
Pages:44
Released:2018-01-17
ISBN:978 0 580 94879 4
Status:Standard
DESCRIPTION

BS EN ISO 11616:2017


This standard BS EN ISO 11616:2017 Health informatics. Identification of medicinal products. Data elements and structures for unique identification and exchange of regulated pharmaceutical product information is classified in these ICS categories:
  • 35.240.80 IT applications in health care technology

This document is intended to provide specific levels of information relevant to the identification of a Medicinal Product or group of Medicinal Products. It defines the data elements, structures and relationships between data elements that are required for the exchange of regulated information, in order to uniquely identify pharmaceutical products. This identification is to be applied throughout the product lifecycle to support pharmacovigilance, regulatory and other activities worldwide. In addition, this document is essential to ensure that pharmaceutical product information is assembled in a structured format with transmission between a diverse set of stakeholders for both regulatory and clinical (e.g. e-prescribing, clinical decision support) purposes. This ensures interoperability and compatibility for both the sender and the recipient.

This document is not intended to be a scientific classification for pharmaceutical products. Rather, it is a formal association of particular data elements categorised in prescribed combinations and uniquely identified when levelling degrees of information are incomplete. This allows for Medicinal Products to be unequivocally identified on a global level.

References to other normative IDMP and messaging standards for pharmaceutical product information are included in Clause 2, to be applied in the context of this document.

Medicinal products for veterinary use are out of scope of this document.